CIK: 0001807489 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 12, 2023
Total Value ($000): $88,443 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WVE | WAVE LIFE SCIENCES LTD | 6,950,000 | $30,094 | 34.0% | $3.30 | +39.0% | SHS | Y95308105 |
| RCKT | ROCKET PHARMACEUTICALS INC | 722,080 | $12,369 | 14.0% | $23.75 | -17.5% | COM | 77313F106 |
| IVVD | INVIVYD INC | 9,248,250 | $11,098 | 12.5% | $17.64 | -89.7% | COM | 00534A102 |
| TGTX | TG THERAPEUTICS INC | 339,500 | $5,106 | 5.8% | $16.30 | -6.8% | COM | 88322Q108 |
| — | SPRINGWORKS THERAPEUTICS INC | 197,700 | $5,089 | 5.8% | $25.89 | — | COM | 85205L107 |
| BBIO | BRIDGEBIO PHARMA INC | 304,700 | $5,052 | 5.7% | $39.38 | -70.4% | COM | 10806X102 |
| IONS | IONIS PHARMACEUTICALS INC | 126,300 | $4,514 | 5.1% | $42.06 | -10.7% | COM | 462222100 |
| STOK | STOKE THERAPEUTICS INC | 532,890 | $4,439 | 5.0% | $22.47 | -59.9% | COM | 86150R107 |
| PRQR | PROQR THRAPEUTICS N V | 1,910,600 | $4,070 | 4.6% | $2.38 | +28.5% | SHS EURO | N71542109 |
| — | CURIS INC | 4,482,142 | $2,671 | 3.0% | $3.68 | — | COM NEW | 231269200 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 67,400 | $1,712 | 1.9% | $33.13 | -5.1% | COM | 04280A100 |
| — | ATARA BIOTHERAPEUTICS INC | 439,300 | $1,274 | 1.4% | $3.28 | — | COM | 046513107 |
| SLN | SILENCE THERAPEUTICS PLC | 145,900 | $905 | 1.0% | $15.25 | — | ADS | 82686Q101 |
| — | NEXIMMUNE INC | 133,442 | $51 | 0.1% | $4.61 | — | COM | 65344D109 |